Healthcare policy and standards stories

Polycystic Ovary Syndrome Renamed to Polyendocrine Metabolic Ovarian Syndrome After Decade of Debate

A global consortium of healthcare experts has officially renamed Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS), a change affecting over 170 million women worldwide. Health experts say the new name better reflects the condition's systemic nature and is expected to improve diagnosis and treatment.